|
|
|
Seciality Formulations |
Oncology |
 |
Bleomycin Inj. 15mg. Vials |
|
Doxorubicin HCL Inj. 10mg, 50mg. Vials |
|
Cyclophosphamide Inj. 100mg, 200mg,
& 1g
Vials |
|
Cyclophosphamide 50mg Tabs 10x10s |
|
Cisplatin Inj. 10mg, 20mg Vials |
|
Tamoxifen Citrate 10mg Tabs. 10x10s |
|
Etoposide 100mg Inj. 5ml Ampoule
|
|
 |
Anaesthetics |
|
Glycopyrrolate 0.2mg/ml
Inj. 10x1ml Ampoules |
|
Doxapram 20mg/ml Inj. 5ml Vials
|
|
|
Anti-Hypertensives |
|
Atenolol
25mg, 50mg, Tabs. 10x14s |
|
Atenolol 100mg Tabs. 10x10s |
|
Enalapril Maleate 2.5mg,5mg,10mg
Tabs
10x10s |
|
|
NSAIDs
(New Product)
|
|
Refecoxib
Tabs. 12.5mg 50mg 10x10s
|
|
|
Anti-Viral
H.I.V.
HEPATITIS B
|
|
Lamivudine
Tabs. 150mg. 10x10s |
|
Lamivudine Tabs. 100mg. 10x10s
|
|
|
Anti-Allergic
(New Product)
|
|
Fexofenadine
120mg Tabs. 6's
|
|
|
Osteoporosis
(New
Product)
|
|
Alendronate
sodium 100mg Tabs. 10x10s
|
|
|
|
|
Chirals |
Resolving Agents |
|
S-(+)-BNP
Acid CAS #:[31593-64-7] |
|
R-(-)-BNP Acid CAS #:[39648-67-4] |
|
S-(-)-(1-Naphthy)ethylamine
CAS
#:[10420-89-0] |
|
R-(+)-(1-Naphthy)ethylamine
CAS
#:[3886-69-9] |
|
S-(-)-(1-Naphthy)ethylamine
CAS
#:[10420-89-0] |
|
R-(+)-(1-Naphthy)ethylamine
CAS
#:[3886-70-21] |
|
Ar = p-toluyl, L-(+)-Ditoluoyltartaric
acid |
|
Ar = Phenyl, L-(+)-Dibezoyltartaric acid
|
|
|
Carbohydrate
Derivatives |
|
b-D-Glucose
Pentaactate CAS #:[604-68-2] |
|
Acetobromo-a-D-glucose
CAS #:[572-09-8] |
|
1,2:5,6-Di-O-isopropylidine-a-D-glucofuranose
CAS #:[582-52-5] |
|
1,2:5,6-Di-O-isopropylidine-a-D-allofuranose
CAS #:[2595-05-03] |
|
3-O-Benzyl-1,2-O-isopropylidine-a-D-xylo-
dialdose CAS
#:[23558-05-6] |
|
R-(+)-(1-Naphthy)ethylamine
CAS #:[3886-70-21] |
|
Diacetone-D-mannitol CAS#:[1707-77-3]
|
|
|
Oxyzolidinones
And
1,2-Amino Alcohols |
|
(S)-4-Phenyl-2-oxazolidinone
CAS #:[99395-88-7] |
|
(R)-4-Phenyl-2-oxazolidinone
CAS#:[90319-52-1] |
|
(S)-4-Benzyl-2-oxazolidinone
CAS #:[90719-32-7] |
|
(R)-4-Benxyl-2-oxazolidinone
CAS#:[102029-44-7] |
|
(S)-4-Isopropyl-2-oxazplidinone
CAS#:[17016-83-0] |
|
(R)-4-Isopropyl-2-oxazolidinone
CAS#:[95530-58-8] |
|
(S)-Phenylglycinol CAS#:[20989-17-7] |
|
(R)-4-Isopropyl-2-oxazolidinone
CAS#:[5267-64-1] |
|
(S)-Phenylalaninol CAS#:[3182-95-4] |
|
(R)-Phenylalaninol CAS#:[5267-64-1] |
|
(S)-Valinol CAS#:[2026-48-4] |
|
(R)-Valinol CAS#:[4276-09-9]
|
|
|
|
Active Pharmaceutical Ingredients |
Immuno
Suppressant |
|
Leflunomide
|
|
|
NSAIDS |
|
Celecoxib |
|
Meloxcam |
|
|
Anti-Viral |
|
Lamivudine
|
|
|
Anti-Spasmodic |
|
Camylofin Di HCl**
|
|
|
Anti-Cholinergic |
|
Glycopyrrolate U.S.P.**
|
|
|
Anti-Tussive |
|
Prenoxdiazine HCl
|
|
|
Muscle
Relaxant |
|
Methocarbamol U.S.P.**
|
|
|
Expectorant |
|
Guaiphenesin B.P/U.S.P.**
|
|
|
|
| UNDER
DEVELOPMENT_________________________ |
|
Chiral |
Glycals |
|
3,4,6-Tri-O-acetyl-D-galactal
CAS#:[4098-06-0] |
|
D-Galactal CAS#:[13265-84-4] |
|
3,4,6-Tri-O-acetyl-D-alucal CAS#:[28730-29-2] |
|
D-Glucal CAS#:[13265-84-4]
|
|
|
Chiral
C5
Synthons |
|
Methyl
3-[(4S)-2,2-dimethyl-1,3-dioxolane-4-yl]-
propionate CAS#:[90472-93-8] |
|
Methyl
3-[(4S)-2,2-dimethyl-1,3-dioxolane-4-yl]-
propanol CAS#:[51268-87-2] |
|
(S)-5-Bromopentane-1,4-diol
CAS #:[110730-97-7] |
|
(S)-5-Bromo-4-(methoxymethoxy)-pentane
nitril
CAS #:[209806-89-3] |
|
(S)-5-Hydroxymethylfuranone
CAS #:[32780-06-9] |
|
(S)-5-(4-Flurophenoxy)
methylbutyrolactone
CAS #:[175212-40-5]
|
|
|
Chiral
C6
Synthons |
|
2-Isopropoxy-6(R)-methyltetrapydro-2H-pyran |
|
2-Isopropoxy-6(R)-methyl-5,6-dihydro-2H-
pyram |
|
(R)-1,5-Hexanediol
CAS #:[71401-68-8] |
|
(R)-5-Hydroxyhex-2E-en-1-one
CAS #:[-85-9]
|
|
|
|
Speciality Formulations |
Liposomal
Doxorubicin |
|
A
Novel Delivery System by
incorporating
hydrogenated Engg
Phosphodyl Choline/Lipid
to enhance stability
profiles,minimize
associated
cardiovascular and other
toxicity and to incrase
therapeutic efficacy in
cancer chemotherapy.
|
|
|
|
|
Liposomal
Amphoteracin B |
|
A
new generation liposomal
preparation, which
is stable, exhibiting
improved pharmacokinetc
pattern and increased
therapeutic
window, is
useful i disseminated
intravascular fungal
infections.
|
|
|
|
|
Hydro
Gel -
Burn Dressings |
|
To
be used as interfaces
between damaged skin
tissue and its external
its external environment
due to burn to
facilitate cooling of
wound surface from
physical trauma and
healing process.
The same gel can also be
used as drug
carrier device in
clinical medicine.
|
|
|
|
|
|
Active Pharmaceutical Ingredients |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
